Is Insulin Pump Therapy More Effective Than Multiple Daily Insulin Injections in Preventing Subclinical Cardiac

Ayşe Güler Eroğlu1, Berfin Altaş Özgür1, Nida Gülderen Kalay Şentürk1

  • 1Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, İstanbul, Turkey.

Insights

Children with type 1 diabetes mellitus (T1DM) on insulin pump therapy (IPT) showed better regional heart muscle mechanics than those on multiple daily insulin injections (MDIIT), despite similar overall heart function. This suggests subtle differences in cardiac health based on insulin delivery method.

Area of Science:

  • Cardiology
  • Pediatrics
  • Endocrinology

Background:

  • Subclinical myocardial dysfunction can occur in pediatric patients with type 1 diabetes mellitus (T1DM).
  • The impact of different insulin delivery methods on myocardial mechanics in T1DM is not well understood.
  • Conventional cardiac function may be preserved despite early cardiac changes.

Purpose of the Study:

  • To compare echocardiographic findings between pediatric T1DM patients using insulin pump therapy (IPT) and multiple daily insulin injections therapy (MDIIT).
  • To assess global and regional myocardial strain using three-dimensional speckle-tracking echocardiography (3D-STE) in relation to insulin delivery modality.

Main Methods:

  • A cross-sectional study involving 56 children and adolescents with T1DM.
  • Participants were divided into IPT (n=27) and MDIIT (n=29) groups.
  • Evaluations included conventional echocardiography, tissue-Doppler imaging, 3D echocardiography, and 3D-STE to analyze strain parameters.

Main Results:

  • No significant differences in global strain parameters or ejection fraction between IPT and MDIIT groups.
  • Patients on IPT demonstrated more favorable regional anteroseptal circumferential and radial strain.
  • The E'/A' ratio was significantly higher in the IPT group.

Conclusions:

  • Both IPT and MDIIT groups showed comparable conventional and global 3D-STE cardiac function.
  • Regional strain differences suggest subtle myocardial abnormalities in MDIIT patients.
  • Further research is needed to determine the clinical significance of these regional differences.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...